PetVivo raises $1.21M via private placement of Series A Preferred and warrants at $0.40/unit

PetVivo Holdings, Inc.

Raised $1,210,000 by selling 3,025,000 units at $0.40/unit to 3 accredited investors.
Each unit consists of one Series A Convertible Preferred share and one warrant exercisable at $0.90 for 3 years.
Series A Preferred converts to common at lesser of $0.40 or higher of $0.25/future offering price; auto-converts after one year.
Company's securities remain suspended from Nasdaq; delisting affirmed but not yet effective.
Proceeds to be used for commercialization of Spryng™, clinical trials, and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.